Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 3, 2001, Pages 287-290

  Russmann, Stefan ^a   Zimmermann, Arthur ^a   Krähenbühl, Stephan ^a   Kern, Beatrice ^a   Reichen, Jürg ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Azathioprine; Hepatocellular carcinoma; Keywords; Nodular regenerative hyperplasia; Pancreatitis; Peliosis hepatis; Ulcerative colitis; Veno occlusive disease

Indexed keywords

AZATHIOPRINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER RESECTION; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS; VEIN OCCLUSION;

AGED; AZATHIOPRINE; CARCINOMA, HEPATOCELLULAR; COLITIS, ULCERATIVE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; MALE;

EID: 0035090185     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200103000-00013     Document Type: Article

References (23)

1. Farrell GC. Drug-Induced Liver Disease, 1st edn. Singapore: Churchill Livingstone; 1994.
2. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O. et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177 -186.
3. Tage-Jensen U, Schlichting P, Thomsen HF, Hoybye G, Thomsen AC. Malignancies following long-term azathioprine treatment in chronic liver disease.: A report from the Copenhagen Study Group for Liver Diseases. Liver 1987; 7: 81 -83.
4. Cattan S, Wendum D, Chazouilleres O, Schmitz J, Gendre JP. Hepatocellular carcinoma and focal hepatic glycogenesis after prolonged azathioprine therapy. Hum Pathol 2000; 31: 874 -876.
5. Gruber S, Dehner LP, Simmons RL. De novo hepatocellular carcinoma without chronic liver disease but with 17 years of azathioprine immunosuppression. Transplantation 1987; 43: 597 -600.
6. Lee FL, Murray SM, Prior J, Shreeve DR. Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine. Hepatogastroenterology 1983; 30: 188. 188.
7. Saeian K, Franco J, Komorowski RA, Adams MB. Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series. Liver Transpl Surg 1999; 5: 46 -49.
8. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249 -1252.
9. Gibson JB, Sobin LH. Histological typing of tumours of the liver, biliary tract and pancreas. In:International Histological Classification of Tumours. Geneva: World Health Organization; 1978.
10. Edmondson HA, Steiner PE. Primary carcinoma of the liver.: A study of 100 cases among 48900 necropsies. Cancer 1954; 7: 462 -503.
11. Read AE, Wiesner RH, LaBrecque DR, Tifft JG, Mullen KD, Sheer RL. et al. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Ann Intern Med 1986; 104: 651 -655.
12. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996; 23: 589 -599.
13. Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J. et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991; 14: 806 -810.
14. Haxhe JJ, Alexandre GP, Kestens PJ. The effect of Imuran and Azaserine on liver function tests in the dog.: Its relation to the detection of graft rejection following liver transplantation. Arch Int Pharmacodyn Ther 1967; 168: 366 -372.
15. Watanabe A, Hobara N, Tobe K, Endo H, Nagashima H. Biochemical and morphological study on hepatotoxicity of azathioprine in rat. Acta Med Okayama 1979; 33: 5 -14.
16. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH. et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608 -614.
17. Buffet C, Cantarovitch M, Pelletier G, Fabre M, Martin E, Charpentier B. et al. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation. Nephrol Dial Transplant 1988; 3: 327 -330.
18. Eland IA, van Puijenbroek EP, Sturkenboom MJ, Wilson JH, Stricker BH. Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in the Netherlands. Am J Gastroenterol 1999; 94: 2417 -2422.
19. Barthet M, Hastier P, Bernard JP, Bordes G, Frederick J, Allio S. et al. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol 1999; 94: 2141 -2148.
20. Hsu CL, Wang CH, Chen RJ, Chen TC. Hepatocellular carcinoma presenting as jaundice, hemobilia, and acute pancreatitis: a case report. Chang Keng I Hsueh Tsa Chih 1998; 21: 232 -236.
21. Bayraktar Y, Egesel T, Saglam F, Balkanci F, Van Thiel DH. Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma? J Clin Gastroenterol 1998; 27: 67 -71.
22. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers.: A clinico-histopathologic study of 804 North American patients [see comments]. Am J Clin Pathol 1996; 105: 65 -75.
23. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol 1996; 91: 879 -884.